Twist Bioscience

Guest Speaker

Alexander Kurze

Chief Operating Officer, SeqOne

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Sed elementum tempus egestas sed. Vitae congue eu consequat ac. Aenean et tortor at risus viverra. Feugiat nisl pretium fusce id velit ut tortor. Fames ac turpis egestas maecenas pharetra convallis posuere. Aliquet nec ullamcorper sit amet risus nullam. Velit ut tortor pretium viverra suspendisse potenti nullam ac. Consequat interdum varius sit amet mattis vulputate enim nulla. Eu nisl nunc mi ipsum faucibus vitae aliquet nec ullamcorper. Pellentesque pulvinar pellentesque habitant morbi. Luctus venenatis lectus magna fringilla urna. Felis bibendum ut tristique et egestas quis ipsum suspendisse ultrices. Non arcu risus quis varius quam quisque id. Nunc sed blandit libero volutpat sed cras ornare arcu dui. Dictumst vestibulum rhoncus est pellentesque elit ullamcorper. Eget nunc lobortis mattis aliquam faucibus purus in. Lacus sed viverra tellus in hac habitasse platea dictumst vestibulum. Scelerisque varius morbi enim nunc faucibus a pellentesque. At elementum eu facilisis sed odio morbi quis. Blandit volutpat maecenas volutpat blandit aliquam. Vel fringilla est ullamcorper eget nulla facilisi etiam dignissim. Mauris nunc congue nisi vitae suscipit tellus mauris.

Enter Presenter 2 Header

Enter Presenter 2 Name

Enter Presenter 2 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 3 Header

Enter Presenter 3 Name

Enter Presenter 3 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 4 Header

Enter Presenter 4 Name

Enter Presenter 4 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 5 Header

Enter Presenter 5 Name

Enter Presenter 5 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 6 Header

Enter Presenter 6 Name

Enter Presenter 6 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Writing the Future of Next-Generation Sequencing

December 9, 2025 | 11 AM - 1 PM GMT

Event Description

Guest Presentation

Networking

Enter Details Header

Guest Speaker

Enter Presenter 2 Header

Enter Presenter 3 Header

Enter Presenter 4 Header

Enter Presenter 5 Header

Enter Presenter 6 Header